Results 151 to 160 of about 155,014 (297)
Who Blames the Moon for Poor Sleep? An Exploratory Online Survey. [PDF]
Cajochen C.
europepmc +1 more source
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata +10 more
wiley +1 more source
Low-Carbon Consumption Intention as Risk Management: Evidence from China on Theory of Planned Behavior, Social Influence, and the Moderating Role of Environmental Concern. [PDF]
Liu K.
europepmc +1 more source
Both cg12821679MAPRE3 methylation and MAPRE3 expression are significantly associated with overall survival (OS) of non‐small cell lung cancer. Meanwhile, MAPRE3 expression significantly modified the effect of smoking cessation on OS. Smoking cessation benefits OS merely for patients with high MAPRE3 expression.
Chao Chen +14 more
wiley +1 more source
"Big Thicket Concept Given Endorsement"
The Huntsville Item newspaper article, titled "Big Thicket Concept Given Endorsement" on Lud E.
The Huntsville Item
core
Prevalence of Suicidal Behavior and Self-Injury Endorsement Among Saudi Medical Students: A Cross-Sectional Study of Academic Year Trajectories and Associated Factors. [PDF]
Haddad BA.
europepmc +1 more source
A urine‐based digital PCR assay targeting two hotspot TERT promoter variants detected bladder cancer with high sensitivity and no false positives in this case–control cohort. The streamlined AbsoluteQ workflow outperformed Sanger sequencing and supports non‐invasive molecular testing for bladder cancer detection.
Anna Nykel +12 more
wiley +1 more source
Patient-reported quality of primary care and facility endorsement in Addis Ababa. [PDF]
Shamebo D, Mebratie AD, Arsenault C.
europepmc +1 more source
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska +13 more
wiley +1 more source

